Maviret
Drug timelines are a Plus or Pro feature.
4 regulatory and trial events tracked for Maviret, covering 2024-07-19 to 2026-07-15. Get the full timeline:
Most recent: EMA Authorised: Maviret (glecaprevir;pibrentasvir) — AbbVie Deutschland GmbH & Co. KG